Monday, 19 December 2016
Early career practitioner fellowships enabling research
 |
| Dr Kirsten Palmer |
Two Monash Health doctors have received Early Career
Practitioner Fellowships from the School of Clinical Sciences at Monash Health
to enable their research into cardiovascular disease and improving outcomes in
complicated pregnancies.
MonashHeart Cardiology Fellow Dr Adam Brown and Monash
Health Senior Registrar in Obstetrics and Gynaecology Dr Kirsten Palmer
received the competitive fellowships, allowing them protected research time.
 |
| Dr Adam Brown |
Dr Brown’s research investigates the physical mechanisms that underlie coronary plaque growth,
which frequently causes heart attacks.
“There
is increasing data to suggest that physical forces (mechanical stresses or
biomechanical forces) are involved in this process, but until recently is has
been impossible to estimate these forces in humans,” said Dr Brown.
“My
research project aims to quantify these physical forces at baseline and see
whether plaque growth can be better predicted.”
If
successful, Dr Brown’s research will bring cardiologists a step towards
personalised medicine, where the risk of a heart attack can be calculated for
each patient in the clinic—rather than from population data, where the results
may not apply to any one individual.
“This
study will also provide valuable mechanistic information for future research to
assess whether plaque growth can be halted (or even regressed) through
manipulation of the physical environment of the plaque,” said Dr Brown.
Fellowship recipient Dr Palmer
hopes to improve pregnancy outcomes for both women and their babies affected by
pre-eclampsia which affects about 5% of pregnancies.
“Pre-eclampsia can cause women
to develop high blood pressure and problems with a number of organs, which
ultimately can require her to be delivered early in the pregnancy to reduce the
risks of disability and death to the mother,” said Dr Palmer.
“This results in significant
risks to the baby due to prematurity. The growth of the baby can also be
affected in pre-eclampsia, increasing the risk of having a small baby.”
Dr Palmer said doctors are
currently limited in their ability to predict which women will develop
pre-eclampsia.
“Pre-eclampsia results from the
placenta releasing factors into the mother’s bloodstream and one of these
factors, known as sFLT-1 e15a, is only made by the placenta.”
“We have shown that sFLT-1 e15a
is greatly increased in the blood of women who have pre-eclampsia,” said Dr
Palmer.
“The goal of my research is to
explore whether we can use this placental specific pre-eclamptic factor to
either predict which women will develop pre-eclampsia or more accurately
diagnose those women with pre-eclampsia earlier in the disease process.”
Both Dr Palmer and Dr Brown
said they are incredibly honoured to receive their fellowships from SCS and are
grateful to have protected research time to enable their research.
SCS researchers working to improve health outcomes for obese children and older adults
 |
| Dr Michelle Blumfield and Dr David Scott |
Dr
David Scott from the Department of Medicine received a Career Development
Fellowship to reduce risk factors for falls and fractures in obese older
Australians while Department of Nutrition and Dietetics’ Dr Michelle Blumfield
will study the impact of sleep in pregnancy on maternal and child weight-related
outcomes.
Dr Scott’s Fellowship, worth $425,000 over four years will address two of Australia’s significant public health issues: our ageing population and obesity epidemic.
“40%
of Australia’s older adult population will soon be obese—while this population
generally have normal life expectancy, they can develop functional disability
at a much younger age than non-obese older adults,” said Dr Scott.
As
an exercise scientist, Dr Scott is particularly interested in how exercise can
reduce disability, and the increasing number of falls and fractures now
occurring in our growing obese older adult population.
“My
research to date has demonstrated that low muscle mass and function (sarcopenia)
and high levels of fat inside our muscles (IMAT) are important risk factors for
falls, osteoporosis and fractures in obese older adults,” said Dr Scott.
“Over
the next four years, I will conduct exercise studies targeting improvements in
muscle and bone health in older adults with obesity, and investigate strategies
to ensure exercise programs are achievable and provide optimal outcomes in this
population.”
By
improving physical function and preventing falls and fractures, Dr Scott
believes his research can help reduce health costs and improve the quality of
life of older adults.
Dr
Blumfield’s research is tackling another serious public health problem, childhood
obesity.
“Strong evidence supports the tracking of overweight and
obesity from infancy to adult life and reduced sleep is a strong risk factor
for obesity in infants, children and adults,” said Dr Blumfield.
Sleep disruption has been linked to increased energy intake, poorer
food choices, decreased signals to stop eating and a lowered metabolism.
“In pregnancy, sleep deprivation has been associated with
higher rates of caesarean section, preterm birth, risk of gestational diabetes
mellitus and postnatal depression, however, no research has examined the
relationship between sleep, diet and maternal-child adiposity using reference
measures.”
Dr Blumfield has developed a research program to optimise
maternal and child weight-related outcomes by improving sleeping practices in
pregnancy.
Dr Blumfield’s
projects include several ‘world
firsts’— the
use of reference methods for sleep measurement in pregnancy with longitudinal
assessment of maternal-child outcomes, and a randomised controlled trial to
test the effect of increased sleep opportunity in pregnancy on prenatal
predictors of childhood obesity.
Drs Scott and Blumfield
thank their supervisors and collaborators, including Professor Peter Ebeling, Professor
Helen Truby, Dr Sean Cain, Professor Euan Wallace and Associate Professor Arul
Earnest.
Monash research brings hope to asthma, COPD and other patients with chronic inflammatory diseases
 |
| Professor Phil Bardin |
Recently
announced National Health and Medical Research Council (NHMRC) funding
will enable Monash Health Translation Precinct researchers and clinicians to
investigate new therapies for patients with asthma, chronic obstructive
pulmonary disease (COPD) and other chronic inflammatory lung diseases.
Asthma
and COPD are the most prevalent diseases of the respiratory system, and impose
a significant burden on the Australian health care system.
In
addition to being a chronic burden, these diseases predispose affected
individuals to frequent viral and bacterial infections, often requiring
emergency department treatment.
The
NHMRC-funded collaborative research project at Monash University, Monash
Health and the Hudson Institute of Medical Research will investigate potential
therapies to reduce the impact of virus infections in patients with COPD and
asthma.
“Virus infections trigger asthma attacks, leading to lung deterioration
and a gradual decline in lung function,” said lead researcher and Director,
Monash Lung and Sleep, Professor Phil Bardin.
“People with asthma have increased levels of a molecule called
transforming growth factor-beta (TGFB), and our team has previously shown that
TGFB increases virus infection by suppressing the innate immune response, the
body’s first line of defence.”
Professor
Bardin’s project will determine the therapeutic potential of TGFB inhibitors that are already approved for
use in humans as well as other novel compounds, to reduce the impact of virus infections
in patients with COPD and asthma.
“Modulating TGFB levels may have a
substantial impact in preventing organ dysfunction, improving quality of life
and reducing the burden on the Australian health care system,” said Professor
Bardin.
“Importantly, these findings are
translatable to other chronic inflammatory conditions in which TGFB is
over-expressed, including chronic lung diseases, as well as diseases involving the
joints, liver, pancreas and kidneys.”
Professor
Bardin said this research has the potential to significantly improve the
quality of life of these patients, while reducing the burden of chronic
diseases on the Australian Health Care system.”
Professor
Bardin’s collaborators include Drs Belinda Thomas and Michael Gantier from the
Hudson Institute of Medical Research, Monash University’s Professor Kate
Loveland and Professor Jack Elias from Brown University, New York.
Professor Eric Morand reappointed as Head, School of Clinical Sciences at Monash Health (SCS)
 |
| Professor Eric Morand |
“I very much look forward to working with everyone in
the coming years as we continue together to advance Monash as a leading
academic medical centre, and as the home of translational research for Monash
University,” said Professor Morand.
Monash Haematology research recognised at HAA
 |
| Associate Professor Wood delivering the Ruth Sanger Oration |
Research at Monash Haematology
was recognised and awarded at the HAA Annual Scientific Meeting in Melbourne
last month, attended by around
1500 national and international delegates.
The event is the combined scientific meeting of
the Haematology Society of Australia and New Zealand (HSANZ), Australian and
New Zealand Society of Blood Transfusion (ANZSBT) and the Australasian Society
of Thrombosis and Haemostasis.
The prestigious Ruth Sanger
Oration was awarded to Associate
Professor Erica Wood, Monash Health haematologist and Head of Monash
University’s Transfusion Research Unit. The award is the highest honour of the ANZSBT made in recognition of a
significant contribution to the field of transfusion medicine.
Associate Professor Wood was recognised for her
research, teaching, service to the ANZSBT and international work.
“It was a great honour to receive the award and deliver the Ruth Sanger
Oration,” said Associate Professor Wood. “My oration focussed on the role of
haemovigilance systems in improving the safety of clinical transfusion in our
region and internationally.”
“While our blood supplies in Australia and New Zealand are very safe, we
still have a lot of work to do about how we use blood in our hospitals – human
error is responsible for many of the serious adverse events related to
transfusion,” said Associate Professor Wood.
Associate
Professor Wood is a member of the World Health Organization expert advisory
panel on transfusion medicine, Vice-President of the International Society of Blood Transfusion, and President of the International
Haemovigilance Network. In
these roles she has worked for more than 20 years to improve blood safety nationally
and internationally.
“We
are privileged to have a transfusion expert of Associate Professor Wood’s
calibre and international reputation championing patient blood management at
Monash Health,” said Associate Professor Jake Shortt, Group leader at the Monash
Health Translation Precinct.
Monash Health haematologist and
Monash University PhD student Dr Ashwini Bennett received the HSANZ New
Investigator scholarship.
This highly competitive award of $60,000 enables Dr Bennett to continue her PhD
at Monash Health and Monash University, where she is investigating novel
markers of thrombosis.
Other
recognition included an oral presentation by Monash Health haematologist Dr
Sumita Ratnasingam, whose research focuses on mantle cell lymphoma (MCL).
Dr
Ratnasingam’s study compared the safety and efficacy of first line
immunochemotherapy (ICT) regimens in treating elderly patients with MCL.
“MCL
accounts for 6% of all non-Hodgkin lymphoma and is a fairly aggressive disease
with an expected survival of less than five years,” said Dr Ratnasingam.
“Despite
the median age of diagnosis being 60-70 years, there is a paucity of treatment
guidelines or clinical trials for elderly MCL to guide our management,
resulting in varied treatment strategies and outcomes.”
Dr
Ratnasingam undertook a retrospective audit of elderly MCL (elderly defined as
age 60 or above) patients in four Victorian tertiary hospitals. The results
confirm that typical older patients with MCL benefit from the same therapies
normally reserved for younger patients.
Monash clinicians and researchers
had 20 abstracts accepted for oral and poster presentations at the Annual Scientific Meeting.
Monash University’s Adjunct Clinical
Associate Professor Stephen Opat is the current President of the HSANZ and was
the convenor of the meeting and chair of the local organising committee with
many other Monash Haematology staff members, including Associate Professor Shortt,
Associate Professor Wood and Dr Zane Kaplan.
An overview of Associate
Professor Wood’s lecture can be found here: http://thelimbic.com/haematology/clinical-transfusion-practice-in-australia-could-be-safer-sanger-oration
13th Annual Kaarene Fitzgerald Public Forum
Latest research on sudden unexpected infant death was highlighted
at the 13th annual Fitzgerald Public Forum hosted by the Ritchie
Centre earlier this month.
Established in 2004, the annual public lecture honours the
outstanding contributions Kaarene Fitzgerald made in over 25 years of service
to medical research into the unsolved problem of sudden infant death syndrome (SIDS).
“This year we heard talks from three outstanding young women who have focused
their research on understanding the factors which contribute to stillbirth and
sudden unexpected death in infancy so that we can reduce these unexplained
deaths that claim so many young lives,” said Professor Rosemary Horne, Deputy
Director of the Ritchie Centre.
NHMRC Early Career Fellow Dr Miranda Davie-Tuck spoke on ‘Setting the placental alarm clock: a way to prevent
stillbirth’ while
Dr Emily Cohen, a final year PhD student in The Ritchie Centre and the current
the Kaarene Fitzgerald Scholarship awardee spoke on ‘Being born too small
and too early: effects on the brain and the heart’.
Dr Rita Machaalani, a postdoctoral research fellow
from the Department of Medicine and the Bosch Institute, University of Sydney
and Department of Paediatrics, Children’s Hospital at Westmead, Sydney spoke about
smoking risks for SIDS.
Professor Horne said Kaarene was passionate in her belief
that research will find a solution for SIDS and that research findings be
translated into clinical practise.
SCS Christmas Party 2016
SCS researcher receives Achievement and Career Development Award
 |
| Dr Connie Wong |
Congratulations Dr Connie Wong, winner of the Australian
Vascular Biology Society’s “Achievement and Career Development” Award.
The competitive award worth $10,000 is a prestigious prize
for early-mid career researchers in recognition of significant achievements and
promotes potential future success.
Dr Wong from the Centre for Inflammatory Diseases, School of
Clinical Sciences at Monash Health (SCS) will use the award to conduct a pilot
study to collaborate with Monash Health stroke clinicians to understand how a
brain injury like stroke can trigger changes in the gut in such a way that
increases the risk of infections in patients.
“The pilot will give us a first look to see whether the
pathways we examined in the experimental settings can be applied in the
clinics,” said Dr Wong.
“If the results are positive, it will be a very significant
step closer to developing powerful and targeted treatment regimens for stroke
patients, ultimately improving patient outcomes.”
Dr Wong said it was a great honour to receive recognition from
her peers, especially from the people who she has admired and drawn inspiration
from over the years.
“This award will facilitate the development of new
collaborations and provide support to generate data, important for upcoming
competitive funding opportunities.”
The award will also help fund Dr Wong’s research group to
travel and attend the next Australian Vascular Biology Society’s meeting in
Mooloolaba.
PhD candidate at SCS recognised for stem cell research to help patients with liver disease
 |
| Majid Alhomrani |
Congratulations SCS PhD candidate Majid Alhomrani who was
selected as one of the six best poster presentations and was awarded a travel
grant at the Australasian Society for Stem Cell Research (ASSCR) Annual
Scientific Meeting in Western Australia earlier this month.
Mr Alhomrani’s research focuses on liver cirrhosis, the
long-term outcome of persistent and unregulated hepatic wound healing in the
setting of ongoing liver injury.
“For many patients who
progress to cirrhosis, a lack of response to existing therapy or the absence of
any effective treatment means that their only prospect for survival is liver
transplantation and there is a clear need for alternatives to whole organ
transplantation for these patients.” Said Mr Alhomrani.
Mr
Alhomrani is investigating the efficacy of human amnion epithelial cells exosome
(hAEC-Ev) which is secreted
nanosized (70-200 nm) membrane vesicles that may act as a novel cell-cell
communicator.
Mr
Alhomrani’s research suggests hAEC EV based therapy may be a potential
candidate for treating liver fibrosis.
Mr
Alhomrani thanks and acknowledges the support of his supervisors Professor
William Sievert, Dr Rebecca Lim and all lab members.
SCS BMedSc(Hons) student wins highest Faculty prize
 |
| Sasha Skinner |
School of Clinical Sciences at Monash Health (SCS) student
Ms Sasha Skinner is the highest achieving BMedSc(Hons) student in the entire
2016 cohort.
Supervised by Dr Ryan Hodges, The Ritchie Centre, Hudson
Institute of Medical Research and the Department of Obstetrics and Gynaecology,
Monash University, Sasha’s project investigated experimental
intra-amniotic carbon dioxide insufflation for fetal surgery to improve outcomes
of babies with spina bifida.
“Prenatal repair of spina bifida
improves neurological outcomes and prevents intracranial complications at birth,”
said Sasha.
“To reduce significant maternal morbidity and high rates of
preterm birth associated with open fetal surgery, fetoscopic spina bifida
repair is proposed as a minimally invasive alternative.”
“Partial amniotic carbon dioxide insufflation (PACI) is one
method to overcome the technical challenges of operating endoscopically in
amniotic fluid.”
PACI involves partially draining amniotic fluid and
insufflating the uterus with carbon dioxide—PACI increases space, improves
visualisation and allows the use of surgical glues.
Sasha said that evidence of fetal safety during PACI is not
well established and in sheep models, PACI causes fetal hypercapnia and
acidosis.
“The effects of PACI on fetal-placental circulation or the
developing fetal brain are unknown,” said Sasha.
“My project assessed the effect of PACI, at clinically used
insufflation pressures, on the fetal-placental circulation, fetal and maternal
acid base status and on the developing fetal brain in a sheep model.”
“We found PACI has detrimental implications for fetal
physiology including large reductions in uterine blood flow, severe fetal
hypercapnia, acidosis, hypoxia and lactic acidosis, increased fetal heart rate
and blood pressure.”
Sasha’s study found that PACI leads to cerebrovascular
changes on fetal brain histology and should not be performed in human fetuses
until further studies have addressed these safety concerns in animal models.
Sasha said her BMedSc(Hons) year had sparked a passion and
research will undoubtedly be something she remains involved in for many years to
come.
“I have learnt so much, not just about science and the
laboratory, but also an unexpectedly large amount about my personal ambitions
and capabilities.”
“I have had a fantastic year and thoroughly enjoyed working
with such passionate and dedicated people.”
SCS student graduates with MBBS and PhD
 |
| Dr Alison Browning and Professor Michelle Leech |
Congratulations Dr Alison Browning who graduated last
week with a double degree.
A student at the School of
Clinical Sciences at Monash Health (SCS) and the Hudson Institute of Medical
Research, Alison was the only student who graduated last Tuesday with her MBBS
and PhD.
Alison's thesis examined the link between stomach inflammation (gastritis) and gastric cancer, the second-most lethal cancer in the world.
"Using a preclinical mouse model which develops gastritis and tumours, we identified the role of a protein complex in the stomach called the inflammasome in triggering the growth of stomach tumours," said Alison.
"Increased expression of these inflammasomes is also observed in human gastric cancer tissue biopsies, suggesting that they may serve as a potential therapeutic target in the future."
Alison was supervised by Associate Professor Brendan Jenkins and Professor William Sievert.
Alison's thesis examined the link between stomach inflammation (gastritis) and gastric cancer, the second-most lethal cancer in the world.
"Using a preclinical mouse model which develops gastritis and tumours, we identified the role of a protein complex in the stomach called the inflammasome in triggering the growth of stomach tumours," said Alison.
"Increased expression of these inflammasomes is also observed in human gastric cancer tissue biopsies, suggesting that they may serve as a potential therapeutic target in the future."
Alison was supervised by Associate Professor Brendan Jenkins and Professor William Sievert.
PhD Confirmation of Candidature - Dr Hanh Nguyen, 22 December
All staff and students are invited to Dr Hanh Nguyen's PhD confirmation of candidature.
Wednesday 22 December, 11:30am - 12:30pm
Surgical Seminar Room, Level 5 Block E, Monash Medical
Centre
Thesis title: Determinants of skeletal fragility in
under-served populations
Synopsis: Women with premature ovarian insufficiency and
populations with atypical femoral fractures represent two underserved groups
with complex bone disease and high fracture risk. The aim of my PhD is to
characterise the clinical, genetic and structural determinants of skeletal
fragility in these two populations, and identify opportunities for targeted
intervention in order to optimise bone health.
Supervisors: Professor Peter R Ebeling, Clinical A/Professor
Frances Milat, Clinical A/Professor Amanda Vincent, A/Professor Carola
Zillikens
Panel Chair: A/Professor Elizabeth Algar
Independent assessors: Professor Peter Fuller and Dr David
Scott
ARC Linkage Projects 2017 (LP17) - OPEN SOON in RMS
Applications
for ARC Linkage Projects 2017 will open for continuous submission in RMS on Friday 23 December 2016.1. Please find attached the Funding Rules (2016 edition), FAQs and changes from last round. Instructions to Applicants will be available for download from the ARC website: http://www.arc.gov.au/linkage-projects on Friday 23 December 2017.
2. For an MRO compliance check, please submit your proposal in RMS. A Pure Application Record will also need to be created and submitted to pre-approval in myResearch/Pure (for guidance refer to: Creating an Application Record)
Call for applications - 2017 Faculty Travel Grant
Under the Faculty Travel Grant Scheme 2017, the School of
Clinical Sciences at Monash Health has been allocated funds sufficient for 11
travel grants of $1000 each. This grant is to be used to support early to
mid-career researchers (Levels A-C) for their international conference
travel, and allocation is contingent upon abstract acceptance. We now
wish to invite applications from eligible SCS staff via the attached
form HERE. Please read the attached guidelines HERE, and submit your
application by Monday 23rd January 2017 to jinleng.graham@monash.edu.
Applications will be jointly assessed by the SCS Executive and you will be notified of the result of your application.
Note: Only salaried staff of School of Clinical Sciences at Monash Health (SCS) are eligible to apply.
Platform Access Grants 2017 (Round 2) - APPLICATIONS NOW OPEN
The Faculty of Medicine,
Nursing and Health Sciences is pleased to announce a call for applications for
a second round of Platform Access
Grants (PAG) for funding commencing in 2017. The timing of this round has
been offset by 6 months from the PAG (Round 1)
scheme administered under the Strategic Grants Scheme 2017 (SGS 2017).
We invite proposals from individuals or
small teams (max. 3 members) requesting Service Fees to
access FMNHS Technology Research Platforms (including
Biostatistics and Bioinformatics), or to purchase Products of these platforms.
Grants of up to
$15,000 will be available for this purpose. Please
note that the “Service Provider” does not have to be a collaborator on the
grant, and if they are not, they must not be listed as a Chief Investigator.
Registrations and applications for the PAG 2017
(R2) scheme
are NOW
OPEN via the Faculty
Grants, Fellowships and Prizes online portal at:
PAG Applicants may find it useful to print out
and refer to the attached PAG 2017 (R2) - Guidelines HERE and PAG
2017 (R2)
- Instructions to Applicants HERE, prior to and whilst
completing the online application form.
Application Closing Date: Thursday
30 March 2017 at 5:00PM (AEDT)
All queries related to the PAG 2017 (R2) scheme and the online application form should be directed to the Faculty Research Office by email to medicine.research@monash.edu, or phone (03) 990 58409.
ARC LIEF (LE18) - EOI Process Now Open
The
EOI process for ARC LIEF grants is now open, and will close at 5pm on
Wednesday 8 February 2017. All EOI's
submitted State-wide from Victoria-based universities will be discussed at a
meeting in mid-February which is attended by the DVCR's or their
delegates. Only those EOI teams who receive approval from this meeting
will be supported to submit a full ARC LE18 application.
To start and EOI, please
access the VicLIEF Portal here: https://monashuniversity.smartygrants.com.au.
Attached is a help sheet HERE for the online
portal.
Monash-led Bids - Internal Cash Commitment
For Monash-led bids, we would
expect that the overall cash contribution from the university would total
between 40% and 60% of the total request for funds and that this would likely
comprise one third from the faculty, one third from the relevant School/Department
and one third from Central.
To secure this internal funding, it is important that School/Department/Faculty signs off on their commitment (thus confirming the strategic importance of the request) before any EoI can be lodged and importantly, before any potential partners are asked to support the application.
To secure this internal funding, it is important that School/Department/Faculty signs off on their commitment (thus confirming the strategic importance of the request) before any EoI can be lodged and importantly, before any potential partners are asked to support the application.
Externally-led Bids - Monash Cash Commitment
For non-led bids there
needs to be signed approval by the lead Institution before sign
off by the relevant School/Department and Faculty regardless of contributions.
Internal Cash Contribution Sign-Off
Sign-off on internal funding sources is achieved via the LE18 Monash Cash Contribution form (attached HERE).
Sign-off on internal funding sources is achieved via the LE18 Monash Cash Contribution form (attached HERE).
Key Dates
Activity
|
Date
|
VicLIEF Portal Opens for EOIs
|
Thursday 15 December 2016
|
VicLIEF Portal Closes
|
Wednesday 8 February 2017, 5pm
|
DVCR’s Meeting
|
w/c 13 February 2017
|
EOI Outcome Notifications
|
17 February 2017
|
RMS Opens
|
Wednesday 8 February 2017
|
RMS Closes
|
Wednesday 5 April 2017, 5pm
|
If you have any queries, please contact mro-arc@monash.edu.
MRO Seminar: Early Career Fellowship Information Session, 18 Jan
The Monash Research
Office (MRO) will
be holding an information session on Wednesday 18th January 2017
for those considering applying
for an Early Career Fellowship (ECF) in 2017.
This session
will discuss matters relating to eligibility and compliance with NHMRC funding
rules for these schemes. We will also cover new MRO compliance checking and
faculty approval processes using the new online system, Pure.
There will be
the opportunity for questions at the end of the presentation.
Date: Wednesday 18th January 2017
Time: 1.30pm - 2.30pm
Location: Central 1 (C1) Lecture Theatre,
Clayton campus
Please register your attendance: here
If you
are unable to attend, the session will
be recorded for later viewing.
The session will
be video-conferenced to the following locations:
Parkville: Dean's
Meeting Room, Lvl G, Bldg 404
Alfred: Board Room 1, Level 6, The Alfred Centre
Hudson Institute:
Level 7, Board Room, Translational Research
Facility (TRF) building
If you
require any further information regarding these sessions, please do not
hesitate to contact us on mhs@monash.edu
or 9902 4427.
MRO Seminar: Career Development Fellowship Information Session, 25 Jan
The Monash Research
Office (MRO) will
be holding an information session on Wednesday 25th January 2017
for those considering applying
for a Career Development Fellowship (CDF) in 2017.
This session
will discuss matters relating to eligibility and compliance with NHMRC funding
rules for these schemes. We will also cover new MRO compliance checking and
faculty approval processes using the new online system, Pure.
There will be
the opportunity for questions at the end of the presentation.
Date: Wednesday 25th January 2017
Time: 2pm - 3pm
Location: Central 1 (C1) Lecture Theatre,
Clayton campus
Please register your attendance: here
If you
are unable to attend, the session will
be recorded for later viewing.
The session will
be video-conferenced to the following locations:
Parkville: Large Meeting Rm, Lvl 5, Bldg 404
AMREP: Board Room 1, Level 6, The Alfred Centre
MHTP:
Level 2
Seminar Rm 3 TRF building
If you
require any further information regarding these sessions, please do not
hesitate to contact us on mhs@monash.edu
or 9902 4427.
We look forward
to seeing you
all there!
veski bulletin: 2017 Premier's Award for Health & Medical Research / applications NOW OPEN
Please help ensure that any young, up and coming postgraduate health or medical research scholars you know apply for this year's Premier's Award for Health and Medical Research [PAHMR].
Since 1995, the Premier’s Award for Health & Medical Research (Premier’s Award) has been awarded annually to recognise the exceptional contributions made by early career health and medical researchers in their PhD studies.
How to apply?
Visit : www.veski.org.au/pahmr
Applications will close 2pm [AEDT] - Wednesday, 25 January 2017.
Important Information for Applicants Submitting to ARC or NHMRC in 2017
Please see the attached information HERE provided by the MRO
regarding Important Information for Applicants Submitting to ARC or NHMRC
in 2017.
If you intend to submit a grant application to the ARC
and/or NHMRC in 2017 please read and keep the attached document which contains
important instructions about how to submit your application in Pure.
Please contact the MRO or MyResearch support team should you
require further assistance.
EXTENDED DEADLINE - FMNHS LabArchives Competition - Win an Apple iPad!
** For those who have submitted a poster already, if you
would like to work on it further until the closing date, please email me (jackie.how@monash.edu)
to let Jackie know and resubmit it before the deadline.
What do I have to do?
Submit a creative poster
on some cool future development to the LabArchives platform that you would like
to see implemented in 2017!
Possible developments
may include:
· Potential
integrations (i.e., systems, platforms)
· Inventive
Widgets
· Solutions
for better efficiency
· Important
problems/bugs that require work
· Possible
solutions to any issues
· New
features
Eligibility
· You
must be an active LabArchives User (at least 2 months)
· You
must be a current graduate research student within FMNHS
Poster specifications
· A2 size
· Can
be portrait or landscape
· Readable
font style and size
· Relevant
pictures/diagrams/designs are welcome
· Final
poster must be submitted in PDF format
Closing date
Friday 20 January 2017,
11:55pm
Email your poster in PDF
format to jackie.how@monash.edu
Changes to Hudson Institute Graphic Services in 2017
Poster printing will be available to our partners at
Monash Health and Monash University but there will be a longer turn-around
time. Please see changes below.
Poster Printing (External)
|
2016
|
2017
|
Cost
|
$55 + GST
|
$100 + GST
|
Timeline
|
1 business day
|
3 business days
|
Express cost (1-2 business days)
|
$110 + GST
|
$150 + GST
|
Please continue to log your jobs for posters via the Graphic
Services Jobdesk.
https://fs8.formsite.com/mimr-phi/graphic_services/index.html
You can also continue to email any queries to graphics@hudson.org.au.
After many years of loyal and excellent service to Prince
Henry’s and the Hudson Institute, Sue Panckridge will be ending her time with
us. Sue was integral to a huge number of
changes at the Hudson Institute during and since the merger including two
changes to our name. I am sure many of you will continue to keep in contact
with her.
Linda Peake will be joining the Hudson Communications
Office in 2017 and will be taking on support for poster printing as well as
other Institute activities.
If you have any queries about these changes please do not
hesitate to contact Ann.scott@hudson.org.au.
A request to please complete the 2016 White Ribbon Survey
White Ribbon is the world’s largest
movement of men and boys working to end men’s violence against women and girls.
Monash University's Executive Director, Campus Community Vladimir A. Prpich is a White
Ribbon Ambassador and a member of the team that saw Monash University
become one of the first Australian employers to be a White Ribbon accredited
workplace.
Monash University is once again part of a pilot group applying for re-accreditation and all staff are requested to complete a brief 10
minute White
Ribbon survey.
Your participation and the
participation of members of your team is a critical part of our
re-accreditation process, and your responses will inform how we can remain a
pioneer in achieving a zero tolerance to violence against women.
Further information on the
campaign and the University’s commitment to a safe workplace for all staff can
be found at our White Ribbon website. Thank you in advance for your
participation.
Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia
Read article here.
Subscribe to:
Posts (Atom)